View Author
patient myeloma thalidomide dexamethasone lenalidomide therapy study treatment response blood trial bortezomib combination survival factor group university cancer regimen serum table month phase hospital disease signi chemotherapy result high-dose progression agent melphalan chain department hematology neutropenia randomized grade palumbo light transplantation cyclophosphamide signi ficantly cell transplantation number novel agents g-csf leukemia risk factors prednisone event doxorubicin meeting abstracts protein high-dose dexamethasone prophylaxi effect myeloma patients oncol institute level stage ef ficacy outcome celgene marrow reduction diagnosis center novel analysis infection recommendation venous thromboembolism venou plasma criteria high-dose therapy guideline incidence
10 Most Recent Publications
|
Plasma cell leukemia: Consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
(Article)
Fernández De Larrea, C. Kyle, R. Kumar, S. Mahindra, A. Comenzo, R.L. Palumbo, A. Mazumber, A. Anderson, K.C. Richardson, P.G. Badros, A.Z. Caers, J. Cavo, M. Durie, B.G.M. Leleu, X. Dimopoulos, M.A. Chim, C.S. Schots, R. Noeul, A. Fantl, D. Mellqvist, U.H. Landgren, O. Chanan-Khan, A. Moreau, P. Ludwig, H. Fonseca, R. Merlini, G. Lahuerta, J.J. Bladé, J. Orlowski, R.Z. Shah, J.J. Usmani, S.M. Vesole, D. Hajek, R. San Miguel, J-F. Sezer, O. Sonneveld, P. |
2013-04-01
|
|
How to manage neutropenia in multiple myeloma
(Article)
Palumbo, A. Bladé, J. Spencer, A. Sonneveld, P. San Miguel, J-F. Boccadoro, M. Palladino, C. Davies, F. Dimopoulos, M.A. Dmoszynska, A. Einsele, H. Moreau, P. Sezer, O. |
2012-02-01
|
|
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
(Article)
Kumar, S. Lee, J.H. Leleu, X. Hulin, C. Klein, S.K. Sonneveld, P. Siegel, D. Bladé, J. Goldschmidt, H. Jagannath, S. Miguel, J.S. Orlowski, R.Z. Lahuerta, J.J. Palumbo, A. Sezer, O. Rajkumar, S.V. Durie, B.G.M. Morgan, G. Richardson, P.G. Crowley, J. Haessler, J. Feather, J. Hoering, A. Moreau, P. |
2012-01-01
|
|
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
(Article)
Kyle, R. Durie, B.G.M. San Miguel, J-F. Avet-Loiseau, H. Hajek, R. Chen, W. Anderson, K.C. Ludwig, H. Sonneveld, P. Pavlovsky, S. Palumbo, A. Richardson, P.G. Rajkumar, S.V. Barlogie, B. Greipp, P. Vescio, R. Turesson, I. Westin, J. Boccadoro, M. Landgren, O. Bladé, J. Merlini, G. Kröger, N. Einsele, H. Vesole, D. Dimopoulos, M.A. |
2010-04-22
|
|
Current multiple myeloma treatment strategies with novel agents: A European perspective
(Article)
Ludwig, H. Beksac, M. Goldschmidt, H. Harousseau, J-L. Hess, U. Ketterer, N. Kropff, M. Mendeleeva, L. Morgan, G. Palumbo, A. Plesner, T. San Miguel, J-F. Bladé, J. Shpilberg, O. Sondergeld, P. Sonneveld, P. Zweegman, S. Boccadoro, M. Cavenagh, J. Cavo, M. Dimopoulos, M.A. Drach, J. Einsele, H. Facon, T. |
2010-02-05
|
|
Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens
(Article)
Kumar, S. Giralt, S. Miguel, J.S. Ludwig, H. Bergsagel, L. Bladé, J. Lonial, S. Anderson, K.C. Tosi, P. Sonneveld, P. Sezer, O. Vesole, D. Stadtmauer, E.A. Cavo, M. Einsele, H. Richardson, P.G. Durie, B.G.M. Rajkumar, S.V. Harousseau, J-L. Palumbo, A. Bensinger, W. Comenzo, R.L. Lentzsch, S. Munshi, N.C. Niesvizky, R. |
2009-11-20
|
|
International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation
(Article)
Palumbo, A. Sezer, O. Kumar, S. Hajek, R. Giralt, S. Bringhen, S. Anderson, K.C. Richardson, P.G. Cavo, M. Davies, F. Bladé, J. Einsele, H. Kyle, R. Dimopoulos, M.A. Spencer, A. Dispenzieri, A. Reiman, T. Shimizu, K. Lee, J.H. Attal, M. Boccadoro, M. Mateos, M.V. Chen, W. Miguel, J.S. Ludwig, H. Joshua, D. Chim, J. Hungria, V. Turesson, I. Durie, B.G.M. Lonial, S. Orlowski, R.Z. Moreau, P. Niesvizky, R. Morgan, G. Comenzo, R.L. Sonneveld, P. |
2009-06-08
|
|
Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma
(Article)
Palumbo, A. Dimopoulos, M.A. Miguel, J.S. Harousseau, J-L. Attal, M. Hussein, M. Knop, S. Ludwig, H. Lilienfeld-Toal, M. Von Sonneveld, P. |
2009-03-01
|
|
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
(Article)
Dispenzieri, A. Kyle, R. Dimopoulos, M.A. Comenzo, R.L. Einsele, H. Barlogie, B. Anderson, K.C. Gertz, M. Harousseau, J-L. Attal, M. Tosi, P. Sonneveld, P. Merlini, G. Boccadoro, M. Morgan, G. Richardson, P.G. Sezer, O. Mateos, M.V. Cavo, M. Joshua, D. Turesson, I. Chen, W. Shimizu, K. Miguel, J.S. Powles, R. Rajkumar, S.V. Durie, B.G.M. Ludwig, H. Hajek, R. Palumbo, A. Jagannath, S. Bladé, J. Lonial, S. |
2009-01-01
|
|
Lenalidomide: A new therapy for multiple myeloma
(Article)
Palumbo, A. Miguel, J.S. Sonneveld, P. Moreau, P. Drach, J. Morgan, G. Einsele, H. |
2008-05-01
|
